Article info
Neurological letter from
Nepal: the pain of stroke treatment
- Correspondence to Bikram Prasad Gajurel, Department of Neurology, Maharajgunj Medical Campus, Tribhuvan University, Institute of Medicine, Kathmandu, Nepal; bikram_gajurel{at}hotmail.com
Citation
Nepal: the pain of stroke treatment
Publication history
- Accepted July 1, 2020
- First published August 20, 2020.
Online issue publication
January 21, 2021
Article Versions
- Previous version (21 January 2021).
- Previous version (21 January 2021).
- Previous version (21 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Management soon after a stroke
- The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
- Blood pressure management in acute stroke
- Recent progress in drug treatment for acute stroke
- Management of acute ischemic stroke
- Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
- Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging
- European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion
- What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers
- Antithrombotic therapy for cerebrovascular disorders